SynthesisFrontiers in pharmacology2026
The impact of ustekinumab and tumor necrosis factor antagonists on extraintestinal manifestations of Crohn's disease: a systematic review and meta-analysis.
Mao-Xuan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.